Syntax Research »

Merck & Co shares owned by Syntax Research

Quarter-by-quarter ownership of Merck & Co (MRK) shares owned by Syntax Research from 13F filings

Historical chart of Syntax Research investment in Merck & Co

Tip: Access up to 7 years of quarterly data

All positions including Merck & Co held by Syntax Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merck & Co by Syntax Research

Quarter filed Position value Share count Share price at filing
2024-03-31 $287k 2.2k 131.95
2023-12-31 $237k 2.2k 109.02

More positions owned by Syntax Research

Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Usa Value (VLUE)
Ishares Tr Core S&p Mcp Etf (IJH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Proshares Tr S&p 500 Dv Arist (NOBL)
Ishares Tr Msci Acwi Ex Us (ACWX)
Ishares Tr Core Msci Euro (IEUR)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Qualcomm (QCOM)
Air Products & Chemicals (APD)
Nutrien (NTR)
Newmont Mining Corporation (NEM)
American Tower Reit (AMT)

View all positions for Syntax Research

Top funds holding Merck & Co

Vanguard Group
Wellington Management Company
Bank of America Corporation
Charles Schwab Investment Management
T. Rowe Price Associates
Norges Bank Investment Management
Jpmorgan Chase & Co
Legal & General Group
Deutsche Bank Aktiengesellschaft
Bank of New York Mellon
Wells Fargo & Company
Royal Bank of Canada
UBS Group
State Farm Mutual Automobile Insurance Company
Fisher Investments

View all funds holding Merck & Co